Uzbekistan to carry out late-stage trial of Chinese COVID-19 vaccine candidate
Uzbekistan will carry out a phase III trial of a coronavirus vaccine candidate developed by China's Anhui Zhifei Longcom Biopharmaceutical Co., the Central Asian nation's ministry of innovative development told Reuters on Wednesday. The deal makes the Zhifei Longcom vaccine the fifth COVID-19

Full story is loading. Click here if it doesn't...